Publication date: June 2018
Source:Biomedicine & Pharmacotherapy, Volume 102
Author(s): Abdoh Taleb, Khalil Ali Ahmad, Awais Ullah Ihsan, Jia Qu, Na Lin, Kamal Hezam, Nirmala Koju, Lei Hui, Ding Qilong
Cardiovascular diseases (CVDs) are considered as the major reason for mortality and morbidity worldwide. Substantial evidence suggests that increased oxidative stress plays a significant role in the pathogenesis of CVDs, including atherosclerosis, hypertension, vascular endothelial dysfunction and ischemic heart disease. Cellular oxidative stress results in the release of toxic free radicals by endothelial cells and vascular smooth muscle cells that interact with cell components such as protein, DNA or lipid resulting in cardiovascular pathology. Silymarin has antioxidant activities against CVDs and offers protection against oxidative stress-induced hypertension, atherosclerosis and cardiac toxicity. We present a comprehensive review regarding the oxidative stress and protective effects of silymarin in CVDs management. We also aim to provide mechanistic insight of the mechanisms of silymarin action in oxidative stress-induced CVDs.
https://ift.tt/2GFdjQN
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Πέμπτη 5 Απριλίου 2018
Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: Available online 22 March 2017 Source: Medical Journal Armed Forces India Author(s): S.C. Shaw, M.S. Vinod, Amit Devgan ...
-
Publication date: April 2017 Source: Biomedicine & Pharmacotherapy, Volume 88 Author(s): Vahideh Alinejad, Sanam Dolati, Morteza Motal...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου